NCT06592755 Single-Incision Gasless Endoscopic Total Thyroidectomy Via Subclavian Approach Versus Open Surgery for PTC
| NCT ID | NCT06592755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University |
| Condition | Papillary Thyroid Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 120 participants |
| Start Date | 2024-09-20 |
| Primary Completion | 2024-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 120 participants in total. It began in 2024-09-20 with a primary completion date of 2024-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Historically, performing a contralateral thyroid lobectomy and lymph node dissection via the subclavian approach was considered challenging. This study aimed to evaluate the safety and feasibility of single-incision gasless endoscopic total thyroidectomy and central compartment neck dissection via the subclavian approach (SCA) in comparison to conventional open surgery for the treatment of papillary thyroid carcinoma (PTC) retrospectively.
Eligibility Criteria
Inclusion Criteria: * (1) thyroid neoplasm \<3.0 cm; * (2) well differentiated papillary thyroid carcinoma. Exclusion Criteria: * (1) extrathyroidal extensions estimated in ultrasonography scan; * (2) enlarged lymph nodes in lateral neck compartment on palpation, or US scan; * (3) suspected distant metastases; * (4) previous history of neck radiation therapy and/or surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06592755 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Papillary Thyroid Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06592755 currently recruiting?
Yes, NCT06592755 is actively recruiting participants. Contact the research team at linpliang3@mail.sysu.edu.cn for enrollment information.
Where is the NCT06592755 trial being conducted?
This trial is being conducted at Guangzhou, China.
Who is sponsoring the NCT06592755 clinical trial?
NCT06592755 is sponsored by Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. The trial plans to enroll 120 participants.